Background:The increasing number of patients suffering from chronic renal disease (CRD) and end-stage renal disease (ESRD) are a challenge for the development of ingenious therapies.Bone marrow (BM) stem cells are an attractive therapy in the treatment of CRD. Aim of the work:This study aims to compare autologous and allogeneic BM cells in treatment of renal damage in a model of unilateral uretera...